Lilly Israel taps XOLTAR to launch a personalized digital patient support program for Type 2 Diabetes and Obesity
Lilly Israel has partnered with XOLTAR to launch a digital patient support program for individuals with Type 2 Diabetes and Obesity. The three-year collaboration aims to improve patient engagement and therapeutic outcomes through video-based support.
Why it matters
This reflects the ongoing trend of pharmaceutical companies integrating digital health tools to manage chronic conditions.
There were 1,580 press releases posted in the last 24 hours and 496,336 in the last 365 days.
LillyGo, powered by XOLTAR, combines personalized digital patient support with XOLTAR’s video-based companion experience.
Three-year collaboration aims to strengthen therapeutic alliance, encourage healthy behaviors and improve long-term engagement.
Asaf Shiloni XOLTAR +1 860-920-7024 Visit us on social media: LinkedIn
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in